Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The shortage of organs has always been a problem in pediatric liver transplants due to the lack of donors with an adequate size. Different techniques of hepatic reduction have been described that allow to use larger organs in the pediatric population. However, in these techniques the maximum reduction achieved by segments 2 and 3 is excessive for low-weight children. Since 1997 the liver transplantation group at Hospital Italiano de Buenos Aires has developed and practiced a technique called hepatic hyper-reduction, which consists in reducing the lateral segment of a living donor, adapting the shape and size of the graft to the needs of the recipient. The investigators have performed approximately 50 pediatric liver transplants with live donors in low weight children in whom the hyper-reduction technique has been applied. The aim of the present study is to describe postoperative morbidity and mortality and analyze overall and graft survival.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hyper-reduced liver recipients. | Low-weight children who underwent live donor liver transplantation with ultrasound-guided in situ left lateral segment graft hyper-reduction. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Liver transplantation with hyper-reduced grafts | Procedure | Live donor liver transplantation using non-anatomical in-situ ultrasound-guided reduction of left lateral segments with preparation of a graft that is larger than a monosegment, but smaller than Segments 2 and 3. |
| Measure | Description | Time Frame |
|---|---|---|
| Overall survival at 1 year. | Overall survival was defined as the time from surgery to death (all causes) or date of last follow-up, measured in months. | Overall survival wil be reported at 1 year after liver transplantation. |
| Overall survival at 3 years. | Overall survival was defined as the time from surgery to death (all causes) or date of last follow-up, measured in months. | Overall survival wil be reported at 3 years after liver transplantation. |
| Overall survival at 10 years. | Overall survival was defined as the time from surgery to death (all causes) or date of last follow-up, measured in months. | Overall survival wil be reported at 10 years after liver transplantation. |
| Graft survival at 1 year. | Graft survival was defined as the time from surgery to the date of re-transplantation or re-entry to waiting list, measured in months. | Graft survival wil be reported at 1 year after liver transplantation. |
| Graft survival at 3 years. | Graft survival was defined as the time from surgery to the date of re-transplantation or re-entry to waiting list, measured in months. | Graft survival wil be reported at 3 years after liver transplantation. |
| Graft survival at 10 years. | Graft survival was defined as the time from surgery to the date of re-transplantation or re-entry to waiting list, measured in months. | Graft survival wil be reported at 10 years after liver transplantation. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
All pediatric patients undergoing living donor liver transplantation with hyper-reduced liver grafts at the Liver Transplantation Unit of the Hospital Italiano de Buenos Aires between June 1997 and April 2018
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Micaela Raices, Physician | Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. | Principal Investigator |
| Matias E Czerwonko, Physician | Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. | Study Chair |
| Victoria Ardiles, Physician | Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. | Study Chair |
| Gustavo Boldrini, Physician | Department of Pediatrics, Division of Pediatric Gastroenterology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. | Study Chair |
| Daniel D'Agostino, Physician | Department of Pediatrics, Division of Pediatric Gastroenterology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. | Study Chair |
| José Marcó del Pont, Physician | Department of Pediatrics, Division of Pediatric Infectious Diseases, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. | Study Chair |
| Juan Pekolj, Doctor | Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Italiano de Buenos Aires | Capital Federal | C1100AAF | Argentina |
Not provided
Not provided
Not provided
Not provided
| Study Chair |
| Eduardo de Santibañes, Doctor | Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. | Study Chair |
| Martin de Santibañes, Physician | Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. | Study Director |
| ID | Term |
|---|---|
| D016031 | Liver Transplantation |
| ID | Term |
|---|---|
| D016378 | Tissue Transplantation |
| D064987 | Cell- and Tissue-Based Therapy |
| D001691 | Biological Therapy |
| D013812 | Therapeutics |
| D013505 | Digestive System Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
| D016377 | Organ Transplantation |
| D014180 | Transplantation |
Not provided
Not provided